Clinical Trials Browser

Not yet recruiting × Carcinoma, Hepatocellular × regorafenib × Clear all

NCT07115550 2025-08-11

A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma

Phase NA Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT07078305 2025-07-22

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular